Pricing Log in Create free account
Saturday 17 October 2026 Export INCY’s income statement to Excel — free account

Incyte Corporation

INCY Healthcare Biotechnology

Incyte Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 21.2% from fiscal 2024. In the quarter to June 2026, revenue grew 37.7%, EPS grew 39.7%, free cash flow grew 1,829.5% and total debt fell 10.5%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.

112.95 0.32 −0.28%
Market cap
$23.0B
P/E
13.9×
Fwd P/E
15.6×
Dividend yield
—
F-score
9/9
Altman Z
8.57
Beneish M
−2.43
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Incyte Corporation (INCY) EV/FCF

Alert me on EV/FCF

As of 16 October 2026, Incyte Corporation (INCY) trades at a EV/FCF of 9.6×. Over the past ten years it has ranged from −14,386× (April 2018) to 853× (November 2024); the current reading is higher than 23% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 11.8× (77.16%)
FY2024 51.8× 111.21%
FY2023 24.5× 51.40%
FY2022 16.2× (33.57%)
FY2021 24.4× —
FY2020 −55.2× —
FY2019 26.4× (42.64%)
FY2018 46.0× —
FY2017 −95.6× —
FY2016 103× (66.20%)

Quarterly newest first

Period EV/FCF Change
Jun 2026 9.6× (7.40%)
Mar 2026 10.4× (12.09%)
Dec 2025 11.8× 1.23%
Sep 2025 11.7× 2.09%
42 more quarters

Against its own ten years

Low −14,386× High 853×
Ten-year median 21.9×
Current reading's percentile 0

EV/FCF against peers

Company EV/FCF
INSM Insmed, Inc. compare −25.4×
ROIV Roivant Sciences Ltd. compare −25.1×
GMAB Genmab A/S Sponsored ADR compare −4.1×
INCY Incyte Corporation 9.6×
BNTX BioNTech SE Sponsored ADR compare 10.7×
EXEL Exelixis, Inc. compare 12.7×
RPRX Royalty Pharma PLC compare 27.0×
ALNY Alnylam Pharmaceuticals, Inc. compare 35.0×
ASND Ascendis Pharma A/S compare 36.4×

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on INCY